Lifeward (NASDAQ:LFWD) Shares Down 2.8% – Here’s What Happened

Lifeward Ltd. (NASDAQ:LFWD) shares traded down 2.8% during trading on Friday . The stock traded as low as $0.67 and last traded at $0.6706. 256,543 shares traded hands during trading, a decline of 35% from the average session volume of 396,353 shares. The stock had previously closed at $0.6898.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. Weiss Ratings reissued a “sell (e+)” rating on shares of Lifeward in a report on Thursday. HC Wainwright reduced their target price on shares of Lifeward from $13.00 to $4.50 and set a “buy” rating for the company in a research note on Tuesday, November 18th. Three analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, Lifeward has an average rating of “Moderate Buy” and an average price target of $6.17.

Lifeward Stock Performance

The company has a market capitalization of $12.27 million and a PE ratio of -0.23. The firm’s 50-day simple moving average is $0.64 and its 200 day simple moving average is $0.66.

Lifeward (NASDAQ:LFWD) last released its quarterly earnings data on Friday, November 14th. The company reported ($0.20) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.06). Lifeward had a negative return on equity of 183.18% and a negative net margin of 121.82%.The company had revenue of $6.20 million for the quarter, compared to analysts’ expectations of $6.31 million. As a group, equities analysts anticipate that Lifeward Ltd. will post -1.78 earnings per share for the current year.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Lifeward stock. Citadel Advisors LLC boosted its holdings in Lifeward Ltd. (NASDAQ:LFWD) by 1,271.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 214,006 shares of the company’s stock after acquiring an additional 198,406 shares during the period. Citadel Advisors LLC owned 1.36% of Lifeward worth $152,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 26.76% of the company’s stock.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.